Adherence to cardiovascular pharmacotherapy by patients in Iraq: a mixed methods assessment using quantitative dried blood spot analysis and the 8-item Morisky Medication Adherence Scale

dc.cclicenceCC-BYen
dc.contributor.authorAlalaqi, Ahmed
dc.contributor.authorLawson, Graham
dc.contributor.authorObaid, Yaseen
dc.contributor.authorTanna, Sangeeta
dc.date.acceptance2021-04-20
dc.date.accessioned2021-05-17T15:50:15Z
dc.date.available2021-05-17T15:50:15Z
dc.date.issued2021-05-14
dc.descriptionopen access articleen
dc.description.abstractThis study evaluated the adherence to prescribed cardiovascular therapy medications among cardiovascular disease patients attending clinics in Misan, Amara, Iraq. Mixed methods were used to assess medication adherence comprising the Arabic version of the eight-item Morisky Medication Adherence Scale (MMAS-8) and determination of drug concentrations in patient dried blood spot (DBS) samples by liquid chromatography-high resolution mass spectrometry. Three hundred and three Iraqi patients (median age 53 years, 50.5% female) who had been taking one or more of the nine commonly prescribed cardiovascular medications (amlodipine, atenolol, atorvastatin, bisoprolol, diltiazem, lisinopril, losartan, simvastatin and valsartan) for at least six months were enrolled. For each patient MMAS-8 scores were determined alongside drug concentrations in their dried blood spot samples. Results from the standardized questionnaire showed that adherence was 81.8% in comparison with 50.8% obtained using the laboratory-based microsample analysis. The agreement between the indirect (MMAS-8) and direct (DBS analysis) assessment approaches to assessing medication adherence showed significantly poor agreement (kappa = 0.28, P=0.001). The indirect and direct assessment approaches showed no significant correlation between nonadherence to prescribed cardiovascular pharmacotherapy and age and gender, but were significantly associated with the number of medications in the patient’s treatment regimen (MMAS-8: Odds Ratio (OR) 1.947, 95% CI, P=0.001; DBS analysis: OR 2.164, 95% CI, P=0.001). The MMAS-8 results highlighted reasons for nonadherence to prescribed cardiovascular pharmacotherapy in this patient population whilst the objective DBS analysis approach gave valuable information about nonadherence to each medication in the patient’s treatment regimen. DBS sampling, due its minimally invasive nature, convenience and ease of transport is a useful alternative matrix to monitor adherence objectively in Iraq to cardiovascular pharmacotherapy. This information combined with MMAS-8 can provide clinicians with an evidence-based novel approach to implement intervention strategies to optimise and personalise cardiovascular pharmacotherapy in the Iraqi population and thereby improve patient health outcomes.en
dc.funderNo external funderen
dc.funder.otherMisan Health Directorate, Ministry of Health, Iraqen
dc.identifier.citationAlalaqi, A., Lawson, G., Obaid, Y., Tanna, S. (2021) Adherence to cardiovascular pharmacotherapy by patients in Iraq: A mixed methods assessment using quantitative dried blood spot analysis and the 8-item Morisky Medication Adherence Scale. PLoS ONE 16 (5): e0251115en
dc.identifier.doihttps://doi.org/10.1371/journal.pone.0251115
dc.identifier.issn1932-6203
dc.identifier.urihttps://dora.dmu.ac.uk/handle/2086/20850
dc.peerreviewedYesen
dc.projectidN/Aen
dc.publisherPLOSen
dc.researchinstituteLeicester Institute for Pharmaceutical Innovation - From Molecules to Practice (LIPI)en
dc.subjectAdherenceen
dc.subjectdried blood spoten
dc.subjectLC-HRMSen
dc.subjectquestionnaireen
dc.titleAdherence to cardiovascular pharmacotherapy by patients in Iraq: a mixed methods assessment using quantitative dried blood spot analysis and the 8-item Morisky Medication Adherence Scaleen
dc.typeArticleen

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
journal.pone.0251115 (1) (1).pdf
Size:
623 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
4.2 KB
Format:
Item-specific license agreed upon to submission
Description: